Arrayit Corporation (ARYC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2014 | 2.57 Million USD | 128.94% |
| 2013 | 1.12 Million USD | -7.66% |
| 2012 | 1.21 Million USD | -18.88% |
| 2011 | 1.5 Million USD | 4.18% |
| 2010 | 1.44 Million USD | 56.61% |
| 2009 | 920.28 Thousand USD | -35.15% |
| 2008 | 1.41 Million USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 40 Thousand USD | -86.71% |
| 2005 | 301 Thousand USD | 224.9% |
| 2004 | -241 Thousand USD | -198.52% |
| 2003 | -80.73 Thousand USD | -244.81% |
| 2002 | 55.75 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2015 Q3 | 371.04 Thousand USD | 12.46% |
| 2015 Q1 | 384.12 Thousand USD | 25.18% |
| 2015 Q2 | 329.92 Thousand USD | -14.11% |
| 2014 Q1 | 381.87 Thousand USD | 265.02% |
| 2014 FY | 2.57 Million USD | 128.94% |
| 2014 Q4 | 306.84 Thousand USD | 46.77% |
| 2014 Q3 | 209.06 Thousand USD | -87.54% |
| 2014 Q2 | 1.67 Million USD | 339.22% |
| 2013 FY | 1.12 Million USD | -7.66% |
| 2013 Q4 | 104.61 Thousand USD | -65.92% |
| 2013 Q1 | 487.4 Thousand USD | 46.22% |
| 2013 Q3 | 306.99 Thousand USD | 35.97% |
| 2013 Q2 | 225.77 Thousand USD | -53.68% |
| 2012 Q4 | 333.34 Thousand USD | 12.91% |
| 2012 Q1 | 215.95 Thousand USD | -53.33% |
| 2012 FY | 1.21 Million USD | -18.88% |
| 2012 Q3 | 295.23 Thousand USD | -20.97% |
| 2012 Q2 | 373.56 Thousand USD | 72.99% |
| 2011 Q4 | 462.74 Thousand USD | 40.49% |
| 2011 FY | 1.5 Million USD | 4.18% |
| 2011 Q2 | 284.73 Thousand USD | -32.96% |
| 2011 Q3 | 329.38 Thousand USD | 15.68% |
| 2011 Q1 | 424.71 Thousand USD | 7.07% |
| 2010 Q1 | 297.01 Thousand USD | 826.34% |
| 2010 FY | 1.44 Million USD | 56.61% |
| 2010 Q4 | 396.66 Thousand USD | -6.63% |
| 2010 Q3 | 424.83 Thousand USD | 31.62% |
| 2010 Q2 | 322.76 Thousand USD | 8.67% |
| 2009 FY | 920.28 Thousand USD | -35.15% |
| 2009 Q2 | 338.21 Thousand USD | 37.81% |
| 2009 Q4 | -40.89 Thousand USD | -110.83% |
| 2009 Q3 | 377.55 Thousand USD | 11.63% |
| 2009 Q1 | 245.41 Thousand USD | -52.49% |
| 2008 Q3 | 222.91 Thousand USD | -62.23% |
| 2008 FY | 1.41 Million USD | 0.0% |
| 2008 Q4 | 516.51 Thousand USD | 131.71% |
| 2008 Q1 | 89.53 Thousand USD | 0.0% |
| 2008 Q2 | 590.2 Thousand USD | 559.23% |
| 2007 Q1 | 54.7 Thousand USD | 304.98% |
| 2007 FY | - USD | -100.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 Q3 | 14.78 Thousand USD | 334.1% |
| 2007 Q2 | -6317.00 USD | -111.55% |
| 2006 Q2 | 18.91 Thousand USD | 257.2% |
| 2006 Q3 | 59.8 Thousand USD | 216.12% |
| 2006 FY | 40 Thousand USD | -86.71% |
| 2006 Q4 | -26.69 Thousand USD | -144.63% |
| 2006 Q1 | -12.03 Thousand USD | -243.56% |
| 2005 Q1 | 11.98 Thousand USD | 110.81% |
| 2005 Q4 | -3503.00 USD | -101.17% |
| 2005 Q3 | 300.51 Thousand USD | 3855.51% |
| 2005 FY | 301 Thousand USD | 224.9% |
| 2005 Q2 | -8002.00 USD | -166.74% |
| 2004 Q1 | -32.73 Thousand USD | -168.8% |
| 2004 Q4 | -110.89 Thousand USD | -134.47% |
| 2004 FY | -241 Thousand USD | -198.52% |
| 2004 Q3 | -47.29 Thousand USD | 5.55% |
| 2004 Q2 | -50.07 Thousand USD | -52.98% |
| 2003 Q1 | -17.94 Thousand USD | 92.92% |
| 2003 Q4 | 47.57 Thousand USD | 171.16% |
| 2003 Q3 | -66.86 Thousand USD | -53.7% |
| 2003 FY | -80.73 Thousand USD | -244.81% |
| 2003 Q2 | -43.5 Thousand USD | -142.4% |
| 2002 Q4 | -253.36 Thousand USD | -401.68% |
| 2002 Q1 | 74.67 Thousand USD | 0.0% |
| 2002 Q3 | 83.98 Thousand USD | 0.0% |
| 2002 FY | 55.75 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 1434.227% |
| Atlantic International Corp. | -154.23 Thousand USD | 1769.579% |
| Biocept, Inc. | -2.58 Million USD | 199.731% |
| Bioqual, Inc. | 7.42 Million USD | 65.338% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -832.992% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.962% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -43.53% |
| iMD Companies, Inc. | -23.63 Thousand USD | 10994.183% |
| IDenta Corp. | 662.97 Thousand USD | -288.41% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 88.825% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -3219.614% |
| InVitro International | 635.98 Thousand USD | -304.893% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 60.764% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -135.664% |
| NovelStem International Corp. | 12 Thousand USD | -21358.817% |
| Optigenex Inc. | -102.96 Thousand USD | 2600.882% |
| PharmChem, Inc. | 3.9 Million USD | 34.047% |
| Proteome Sciences plc | 2.09 Million USD | -22.819% |
| Response Genetics, Inc | 3.94 Million USD | 34.676% |
| Rennova Health, Inc. | 6.26 Million USD | 58.919% |
| RushNet, Inc. | 1.1 Million USD | -133.118% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -200.623% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 737.79% |
| Todos Medical Ltd. | 4.31 Million USD | 40.254% |